Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients (Q24684280)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients	scientific article

Statements

scholarly article

0 references

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients (English)

0 references

transplantation

0 references

1 reference

based on heuristic

inferred from title

author name string

P Quittet

1

0 references

P Ceballos

2

0 references

E Lopez

3

0 references

Z Y Lu

4

0 references

P Latry

5

0 references

C Becht

6

0 references

E Legouffe

7

0 references

N Fegueux

8

0 references

C Exbrayat

9

0 references

D Pouessel

10

0 references

V Rouillé

11

0 references

J P Daures

12

0 references

B Klein

13

0 references

J F Rossi

14

0 references

language of work or name

0 references

publication date

August 2006

0 references

Bone Marrow Transplantation

0 references

38

0 references

4

0 references

275-84

0 references

Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

7 April 2017

Stem cell transplantation in multiple myeloma (0, 1, or 2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Autologous stem cell transplantation in hematological malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Manipulating dendritic cell biology for the active immunotherapy of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

GM-CSF-based cancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF/G-CSF in non-Hodgkin's lymphoma patients: a randomized prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Colony-stimulating factors and peripheral blood progenitor cell transplantation. Benefits and costs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Optimization of peripheral blood stem cell mobilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

28 September 2017

Biologic effects and potential clinical applications of Flt3 ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

30 May 2018

Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2100150

30 May 2018

Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705441

21 January 2018

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705441

21 January 2018

Differential mobilization of CD34+ cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705441

21 January 2018

Relation between harvest success and outcome after autologous peripheral blood stem cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705441

21 January 2018

CD34 counts to predict the adequate collection of peripheral blood progenitor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for long-term engraftment of autologous blood stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignan

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised study of 10 microg/kg/day (single dose) vs 2 x 5 microg/kg/day (split dose) G-CSF as stem cell mobilisation regimen in high-risk breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of the progenitor cell yield in a leukapheresis product by previous measurement of CD34+ cells in the peripheral blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF

1 reference

https://pubmed.ncbi.nlm.nih.gov/16883311

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BMT.1705441

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24684280&oldid=2175229924"